Incidence of rebound salicylate toxicity following cessation of urine alkalinization.
Mary M O'KeefeMatthew StantonRyan FeldmanJillian TheobaldPublished in: Clinical toxicology (Philadelphia, Pa.) (2023)
In patients with salicylate toxicity, the incidence of rebound in serum salicylate concentration after cessation of urine alkalinization, is low. Even if serum salicylate rebounds to supratherapeutic concentrations, symptoms are often absent or mild. Routine repeat serum salicylate concentrations after urine alkalinization is stopped may be unnecessary unless symptoms recrudesce.